Howrah, India

Abhisek Banerjee

USPTO Granted Patents = 11 


 

Average Co-Inventor Count = 6.8

ph-index = 4

Forward Citations = 37(Granted Patents)


Location History:

  • West Bengal, IN (2015 - 2019)
  • Howrah, IN (2013 - 2021)

Company Filing History:


Years Active: 2013-2021

Loading Chart...
Loading Chart...
Loading Chart...
11 patents (USPTO):Explore Patents

Title: Abhisek Banerjee: Innovator in Potassium Ion Channel Inhibitors

Introduction

Abhisek Banerjee is a notable inventor based in Howrah, India. He has made significant contributions to the field of pharmacology, particularly in the development of potassium ion channel inhibitors. With a total of 11 patents to his name, Banerjee's work has the potential to impact the treatment of various cardiac and ion channel-related disorders.

Latest Patents

Among his latest patents is a groundbreaking invention titled "Quinazolines as potassium ion channel inhibitors." This patent describes a compound of formula I, wherein A, X, Y, Z, R, and R are specified. The compounds developed by Banerjee are particularly useful as inhibitors of potassium channel function and are aimed at the treatment and prevention of arrhythmia and other disorders mediated by ion channel function.

Career Highlights

Throughout his career, Abhisek Banerjee has worked with prominent companies in the pharmaceutical industry. Notably, he has been associated with Bristol-Myers Squibb Company and Glenmark Pharmaceuticals S.A. His experience in these organizations has contributed to his expertise in drug development and innovation.

Collaborations

Banerjee has collaborated with several professionals in his field, including Satheesh Kesavan Nair and Venkatram Reddy Paidi. These collaborations have likely enhanced his research and development efforts, leading to his successful patent applications.

Conclusion

Abhisek Banerjee stands out as an influential inventor in the realm of potassium ion channel inhibitors. His innovative work and numerous patents reflect his commitment to advancing medical science and improving patient outcomes.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…